Cardiotoxicity of cancer chemotherapy: implications for children.
about
Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patientsCyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patientsDifferent anthracycline derivates for reducing cardiotoxicity in cancer patientsDifferent anthracycline derivates for reducing cardiotoxicity in cancer patientsCyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patientsDifferent dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapyDifferent dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapyDifferent anthracycline derivates for reducing cardiotoxicity in cancer patientsCardiotoxicity in childhood cancer survivors: strategies for prevention and managementCurrent Views on Anthracycline Cardiotoxicity in Childhood Cancer SurvivorsPI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cellsHypolipidemic, antioxidant, and antiinflammatory activities of microalgae Spirulina.Manganese superoxide dismutase: beyond life and deathReview of cardiotoxicity in pediatric cancer patients: during and after therapy.Impairments that influence physical function among survivors of childhood cancerManganese superoxide dismutase: guardian of the powerhouse.Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.Pregnancy-associated cardiomyopathy in survivors of childhood cancerMetabolism and transport of oxazaphosphorines and the clinical implications.Survivor typologies predict medical surveillance participation: the childhood cancer survivor studySurvivor profiles predict health behavior intent: the Childhood Cancer Survivor StudyAnthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management.Medical screening participation in the childhood cancer survivor study.Predictive toxicology approaches for small molecule oncology drugs.Outcome of hematopoietic stem cell transplant in children with congenital heart disease.Evidence-based risk assessment and recommendations for physical activity clearance: Consensus Document 2011.The new challenging pediatric patient.Cardiotoxicity of childhood cancer treatment: update and current knowledge on long-term follow-up.Curbing cancer's sweet tooth: is there a role for MnSOD in regulation of the Warburg effect?Educational paper: decreasing the burden of cardiovascular disease in childhood cancer survivors: an update for the pediatrician.Cyclophosphamide-associated cardiotoxicity in a child after stem cell transplantation for β-thalassemia major: case report and review of the literature.Treatment-related cardiotoxicity in survivors of childhood cancer.Pharmacogenetics of anthracyclines.Suppression of Reserve MCM Complexes Chemosensitizes to Gemcitabine and 5-Fluorouracil.Chemotherapy-induced cardiotoxicity in children.Evaluation of a urinary multi-parameter biomarker set for oxidative stress in children, adolescents and young adults.Characteristics and determinants of adiposity in pediatric cancer survivors.Effect of Metformin and Sitagliptin on Doxorubicin-Induced Cardiotoxicity in Rats: Impact of Oxidative Stress, Inflammation, and ApoptosisCardiotoxicity and cancer therapy.Chemotherapy-related cardiotoxicity: are Australian practitioners missing the point?
P2860
Q24186938-1F460C55-E95E-4E6F-A097-253CDF698B62Q24202196-18E1C37D-8133-4DEA-BB2B-E0A629CE5F6DQ24235507-D3DA8EF7-3A9E-404F-AC64-37F602CCA608Q24236622-468579F6-3323-42CB-BF04-2013D9BBEB5FQ24240032-232C7580-C3CE-4013-A76A-86652EF236E7Q24240568-E7A6B6FD-3E99-46C7-A741-43411FDF6B8CQ24243810-E9C54611-673F-4033-BD8C-B1AB7AD7CF0DQ24244087-CEA40B55-3CEE-4BC9-AB07-386F411EC272Q24628695-A69802F7-A312-4C1E-953D-70898CEC5C5DQ28083073-2285715D-5CEB-4C78-A733-398917CD064AQ28484680-B60837D9-8A36-4BA5-B9F8-ECA15A3771B2Q34007774-CA90B754-8D78-4542-B222-DC8B102D685EQ34284548-AA9F2B58-619D-4F5B-A6B0-754087CD07C5Q35008126-7FBF0D67-0DD4-4A96-A473-1A10C66FAD7BQ35082766-7DCD9E78-4D05-4837-8CB4-F0F8FD90744CQ35536092-62BCA558-5DBB-4B1F-9C36-FFA7B20CB1D8Q35562745-3C05A0AA-38E2-4D06-A98D-18B483D7F9A6Q36348929-5883BCD4-38DE-4A7D-BAFB-2F76A4E85D52Q36360811-DCD527CE-B06A-4420-BDEF-ECFD792E83D5Q36542308-7E092708-DCEB-4A46-B4C8-322A3EA7B360Q36584433-22304018-37CA-4BE0-B02A-EA1D65A60564Q36828128-072CF3E3-3A12-4786-88A4-5EDA431EA64BQ37125629-0D89FAC2-8C8E-4160-AE29-F372476A0C8EQ37675456-75C9F598-83AD-4636-895E-3603F8FC7AA9Q37719670-CC9F101D-4428-4FA7-A701-7EBE4463A91BQ37908100-F431AA90-63AB-43C2-838E-B4D5032B7B79Q38010733-7F09DD61-2FFD-4BC2-9F48-EDBF01EACDF8Q38021523-D1923D15-5197-459A-B65B-A98A2042308CQ38028251-A2EF826F-9448-4DDB-82C1-5FE2553E7FBCQ38077713-11AF107E-38C8-413F-88EA-00A197233906Q38154349-75963D5B-145D-445A-9773-30625DA520D5Q38156036-39156851-B506-4FFB-A435-96A0E4E778F6Q38856218-C48BBC91-441B-4517-B3C6-FF7E81B95C45Q38865133-3D2475D0-4758-4977-8E36-00A6F0747CAAQ39415815-18363C99-ABCD-45E7-90B9-B6843EF4D0EAQ40277948-AC591CA1-FCD4-4581-AAED-6CA000DEF652Q41411183-99E1CBD4-996B-4BC4-BB73-848A3642537CQ42542336-C073FC1E-4D86-44E1-8C99-510686050951Q44019172-F75DE24C-6D57-4E1F-973A-C537F8E21D40Q48172409-54E27218-A3E6-47FB-8E88-9ACC780D4CF8
P2860
Cardiotoxicity of cancer chemotherapy: implications for children.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Cardiotoxicity of cancer chemotherapy: implications for children.
@ast
Cardiotoxicity of cancer chemotherapy: implications for children.
@en
type
label
Cardiotoxicity of cancer chemotherapy: implications for children.
@ast
Cardiotoxicity of cancer chemotherapy: implications for children.
@en
prefLabel
Cardiotoxicity of cancer chemotherapy: implications for children.
@ast
Cardiotoxicity of cancer chemotherapy: implications for children.
@en
P2093
P1433
P1476
Cardiotoxicity of cancer chemotherapy: implications for children.
@en
P2093
Gul H Dadlani
Sarah A Duffy
Tracie L Miller
Valeriano C Simbre
P304
P356
10.2165/00148581-200507030-00005
P577
2005-01-01T00:00:00Z
P6179
1011604992